摘要
目的评价2013年至2015年南京地区抗耐甲氧西林金黄色葡萄球菌(MRSA)药物应用状况。方法应用金额排序法和用药频度(DDDs)排序法,对34家入网医院2013年至2015年临床使用的抗MRSA药物进行统计和分析。结果 2013年至2015年,抗MRSA药物用药总金额呈逐年上升趋势,其中糖肽类用药金额占比最大。DDDs排序居前列的为万古霉素和替考拉宁。结论 2013年至2015年,该地区抗MRSA药物用药金额呈逐年增长趋势,应加强对抗MRSA药物的临床应用评价工作,从而促进合理用药,提高疗效,减少耐药性。
Objective To evaluate the utilization status and trend of anti-MRSA drugs in Nanjing from 2013 to 2015. Methods To analyze and sum up the use of anti-MRSA drugs in 34 Nanjing hospitals from 2013 to 2015 by using the methods of DDDs analysis and ranking of amount of money. Results The consumption sum of anti-MRSA drugs increased year by year, glycopeptide antibiotics sales constitute the largest amount in anti-MRSA drugs. The top 2 in term DDDs were Vancomycin and Teicoplanin from 2013 to 2015. Conclusion The consumption sum of anti-MRSA drugs increased yearly should strengthen the evaluation of clinical application so as to promote rational clinical application to improve curative effect and reduce the drug resistance.
作者
顾婕
Gu Jie(The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China 210009)
出处
《中国药业》
CAS
2017年第7期75-78,共4页
China Pharmaceuticals
基金
江苏高校优势学科建设工程资助项目[苏政办发〔2011〕6号]
